SCHEMBL6723256

SCHEMBL6723256

O=S(=O)(Cc1ccc(-c2ncccc2-c2cccc(OC(F)(F)F)c2)cc1F)Cc1ccc(-c2ncccc2-c2cccc(OC(F)(F)F)c2)cc1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 1/20 0.46
KCNH2 Q12809 1/20 0.46
CHRM5 P08912 1/20 0.41
DHODH Q02127 3/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.40
PDE4A P27815 3/20 0.38
PDE4B Q07343 3/20 0.38
PDE4D Q08499 3/20 0.38
PDE4C Q08493 2/20 0.38
DYRK1A Q13627 1/20 0.38
SYK P43405 1/20 0.38
SLC40A1 Q9NP59 1/20 0.37
SLC6A7 Q99884 1/20 0.37
KCNK3 O14649 1/20 0.37
BTK Q06187 1/20 0.37
NPY5R Q15761 1/20 0.37
SUCNR1 Q9BXA5 1/20 0.37
CBFB Q13951 1/20 0.36
FEN1 P39748 1/20 0.36
GRM5 P41594 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6723873 0.91 CHRM5 (0.40) KCNA5KCNH2CHRM5CBFB
SCHEMBL6722435 0.84 KCNA5 (0.46) KCNA5KCNH2SUCNR1FEN1
SCHEMBL6723304 0.84 FFAR1 (0.38) FEN1
SCHEMBL6720849 0.84 FEN1 (0.35) FEN1
SCHEMBL6730237 0.84 FEN1 (0.41) DHODHFEN1
SCHEMBL7541582 0.82 DHODH (0.43) KCNA5KCNH2DHODHPDE4APDE4B
SCHEMBL6722623 0.82 PTGES2 (0.44) KCNA5KCNH2DHODHPDE4APDE4B
SCHEMBL6729663 0.82 RPS6KA3 (0.47) KCNA5KCNH2CHRM5DHODHDYRK1A
SCHEMBL6718600 0.82 GLO1 (0.42) FEN1
SCHEMBL6721604 0.82 PTGS2 (0.51) FEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040092552-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2004-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092552-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation FPR2, PTGES2, FPR1 KCNA5 4485/4885KCNH2 3894/4885CHRM5 3140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.